Expression of the Brn-3b transcription factor correlates with expression of HSP-27 in cancer and is required for maximal activation of the HSP-27 promoter

Cancer Research

Volumn 65, Issue 8, 2005, Pages 3072-3080

  Lee, Sonia A ^a   Ndisang, Daniel ^a   Patel, Chandrakant ^a   Dennis, Jonathan H ^d   Faulkes, David J ^a   D'Arrigo, Corrado ^b   Samady, Laila ^a   Farooqui Kabir, Saleha ^a,c   Heads, Richard J ^c   Latchman, David S ^a   Budhram Mahadeo, Vishwanie S ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 27; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR POU4F2; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; BREAST CANCER; CANCER CELL; CHROMATIN; CONTROLLED STUDY; CORRELATION ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; RNA INTERFERENCE; SITE DIRECTED MUTAGENESIS; TUMOR BIOPSY;

EID: 20244381126     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-2865     Document Type: Article

References (37)

1. Jamerson MH, Johnson MD, Dickson RB. Dual regulation of proliferation and apoptosis: c-myc in bitransgenic rnurine mammary tumor models. Oncogene 2000;19:1065-71.
2. Sicinski P, Donaher JL, Parker SB, et al. Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 1995;82:621-30.
3. Ciocca DR, Fanelli MA. Estrogen receptors and cell proliferation in breast cancer. Trends Endocrinol Metab 1997;8:313-21.
4. Hansen RK, Parra I, Lemieux P, Oesterreich S, Hilsenbeck SG, Fuqua SA. Hsp27 over expression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat 1999;56:187-96.
5. Lemieux P, Oesterreich S, Lawrence JA, et al. The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 1997;17:113-23.
6. Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines. Cancer Res 1993;53:4443-8.
7. Rochefort H, Liaudet E, Garcia M. Alterations and role of human cathepsin D in cancer metastasis. Enzyme Protein 1996;49:106-16.
8. Johnson MD, Torri JA, Lippman ME, Dickson RB. The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 1993;53:873-7.
9. Spyratos F, Maudelonde T, Brouillet JP, et al. Cathepsin D: an independent prognostic factor for metastasis of breast cancer. Lancet 1989;2:1115-8.
10. Dennis JH, Budhram-Mahadeo V, Latchman DS. The Brn-3b POU family transcription factor regulates the cellular growth, proliferation, and anchorage dependence of MCF7 human breast cancer cells. Oncogene 2001;20:4961-71.
11. Budhram-Mahadeo V, Ndisang D, Ward T, Weber BL, Latchman DS. The Brn-3b POU family transcription factor represses expression of the BRCA-1 anti-oncogene in breast cancer cells. Oncogene 1999;18: 6684-91.
12. Ryan AK, Rosenfeld MG. POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 1997;11:1207-25.
13. Theil T, Rodel B, Spiegelhalter F, Moroy T. Short isoform of POU factor Brn-3b can form a heterodimer with Brn-3a that is inactive for octamer motif binding. J Biol Chem 1995;270:30958-64.
14. Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F. Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 2000;18:561-4.
15. Xiang M. Requirement for Brn-3b in early differentiation of postmitotic retinal ganglion cell precursors. Dev Biol 1998;197:155-69.
16. Irshad S, Pedley RB, Anderson J, Latchman DS, Budhram-Mahadeo V. The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J Biol Chem 2004;279:21617-27.
17. Budhram-Mahadeo V, Parker M, Latchman DS. POU transcription factors Brn-3a and Brn-3b interact with the estrogen receptor and differentially regulate transcriptional activity via an estrogen response element. Mol Cell Biol 1998;18:1029-41.
18. Samady L, Dennis J, Budhram-Mahadeo V, Latchman DS. Activation of CDK4 gene expression in human breast cancer cells by the Brn-3b POU family transcription factor. Cancer Biol Ther 2004;3:317-23.
19. Buchner A, Oberneder R, Riesenberg R, Keiditsch E, Hofstetter A. Expression of plakoglobin in renal cell carcinoma. Anticancer Res 1998;18:4231-5.
20. Vargas-Roig LM, Gago FE, Tello O, Aznar JC, Ciocca DR. Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy. Int J Cancer 1998;79:468-75.
21. Vargas-Roig LM, Fanelli MA, Lopez LA, et al. Heat shock proteins and cell proliferation in human breast cancer biopsy samples. Cancer Detect Prev 1997;21:441-51.
22. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002;16:948-58.
23. Farooqui-Kabir SR, Budhram-Mahadeo VS, Lewis H, Latchman DS, Marber MS, Heads RJ. Regulation of Hsp27 expression and cell survival by the POU transcription factor Brn3a. Cell Death Differ 2004;11:1242-4.
24. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. In: The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
25. Oda E, Ohki R, Murasawa H, et al. Noxa, a BHS-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000;288:1053-8.
26. Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 1999;274:15237-44.
27. L. J Biol Chem 2003;278:18022-9.
28. Porter W, Wang F, Duan R, et al. Transcriptional activation of heat shock protein 27 gene expression by 17β-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists. J Mol Endocrinol 2001;26:31-42.
29. Oesterreich S, Hickey E, Weber LA, Fuqua SA. Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells. Biochem Biophys Res Commun 1996;222:155-63.
30. Oesterreich S, Lee AV, Sullivan TM, Samuel SK, Davie JR, Fuqua SA. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cells. J Cell Biochem 1997;67:275-86.
31. Dunn DK, Whelan RD, Hill B, King RJ. Relationship of HSP27 and oestrogen receptor in hormone sensitive and insensitive cell lines. J Steroid Biochem Mol Biol 1993;46:469-79.
32. Cottone E, Orso F, Biglia N, Sismondi P, De Bortoli M. Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity. Int J Biol Markers 2001;16:151-66.
33. Dickson RB, Stancel GM. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 2000;135-45.
34. Murphy L, Cherlet T, Lewis A, Banu Y, Watson P. New insights into estrogen receptor function in human breast cancer. Ann Med 2003;35:614-31.
35. Iwase H. Molecular action of the estrogen receptor and hormone dependency in breast cancer. Breast Cancer 2003;10:89-96.
36. Oesterreich S, Zhang Q, Hopp T, et al. Tamoxifen-bound estrogen receptor (ER) strongly interacts with the nuclear matrix protein HET/SAF-B, a novel inhibitor of ER-mediated transactivation. Mol Endocrinol 2000;14:369-81.
37. Rust W, Kingsley K, Petnicki T, Padmanabhan S, Carper SW, Plopper GE. Heat shock protein 27 plays two distinct roles in controlling human breast cancer cell migration on laminin-5. Mol Cell Biol Res Commun 1999;1:196-202.